Microplate Dx

Microplate Dx is a diagnostics biotechnology company developing a rapid antibiotic susceptibility testing platform for use at the point of care.

Its biosensor technology uses hydrogel-modified electrodes loaded with antibiotics to determine the most effective treatment for a patient's bacterial infection in under one hour, compared to several days with conventional methods.

The first application targets UTIs, with broader applicability across healthcare settings globally. The company is advancing toward clinical trials and commercial launch.